Approval · Notice of Compliance 24394 · 2020
ULTRAVATE: Notice of Compliance 24394
Issued October 8, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24394
- Date
- October 8, 2020
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form, strength, indication and manufacturing site for drug substance
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ULTRAVATE | Not yet assigned | — |
Medicinal ingredients
- HALOBETASOL PROPIONATE 0.01 PER per NIL
- HALOBETASOL PROPIONATE 0.05 PER